Eradication of Helicobacter pylori and Its Effect in Peptic Ulcer Disease

References

• Penston J G, Wormsley K G. Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther 1992; 6: 3–29
   PubMed Web of Science ®Google Scholar
• Ómorain C, Gilvarry J. Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol 1993; 28(Suppl 196)30–3
   Google Scholar
• Coglan J G, Gilligan D, Humphries H. Campylobacter pylori and recurrence of duodenal ulcers: a 12-month follow-up study. Lancet 1987; 2: 1109–11
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
   PubMed Web of Science ®Google Scholar
• Smith A C, Price A B, Borriello P, Levi A J. A comparison of ranitidine and tripotassium dicitratobismuthate (TDB) in relapse rates of duodenal ulcer. The role of Campylobacter pylori (CP). Gastroenterology 1988; 94: A431
   Web of Science ®Google Scholar
• Rauws E A, Tytgat G NJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990; 335: 1233–5
   PubMed Web of Science ®Google Scholar
• Georg L L, Borody T J, Andrews P. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9
   PubMedGoogle Scholar
• Patchett S, Beattie S, Leen E, Keane C, Ómorain C. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992; 87: 24–7
   PubMedGoogle Scholar
• Coelho L GV, Passos M CF, Chausson Y. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol 1992; 27: 362–6
   PubMed Web of Science ®Google Scholar
• Bayerdörffer E, Mannes G, Sommer A. Long term follow-up after Helicobacter pylori eradication with combined omeprazole and amoxycillin treatment. Eur J Gastroenterol Hepatol 1992; 4: 697–702
   Web of Science ®Google Scholar
• Tytgat G NJ, Axon A TR, Dixon M F (1990) Helicobacter pylori: causal agent in peptic ulcer disease? Working Party Report. World Congresses of Gastroenterology, SydneyAustralia, 26–31 August, 1990. Blackwell Scientific Publications, Melbourne, 36–45
   Google Scholar
• Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 16: 131–7
   Google Scholar
• Hepps K S, Ramirez F C, Lew G M, Saeed Z A, Graham D Y. Treatment of H. pylori reduces the rate of rebleeding in complicated peptic ulcer disease. Gastrointest Endosc 1992; 38: 234
   Google Scholar
• O'Connor H J, Axon A TR. Campylobacter pylori, gastric ulceration and the post-operative stomach. Campylobacter pylori and gastro-duodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989; 125–38
   Google Scholar
• Tatsuta M, Ishikawa H, Iishi H, Okuda S, Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut 1990; 31: 973–6
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G L, Klein P D. Effect of treatment of Helicobacter pylori infection on long term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705–8
   PubMed Web of Science ®Google Scholar
• Bayerdörffer E, Mannes G A, Hochter W. Antibacterial treatment of gastric ulcers–German gastric ulcer study. Ir J Med Sci 1992; 161(Suppl 10)30
   Google Scholar
• Weil J, Bell G D, Powell K U. Helicobacter pylori infection treated with a tripotassium dicitrato-bismuthate and metronidazole combination. Aliment Pharmacol Ther 1990; 4: 651–7
   PubMed Web of Science ®Google Scholar
• Bell G D, Weil J, Powell K U. Helicobacter pylori treated with combinations of tripotassium dicitrato-bismuthate and metronidazole: efficacy of different regimens and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991; 3: 819–22
   Web of Science ®Google Scholar
• Bell G D, Weil J, Powell K U. Helicobacter pylori treated with Pivampicillin alone or in combination with bismuth sub-citrate. Aliment Pharmacol Ther 1991; 5: 543–7
   PubMedGoogle Scholar
• Bell G D, Powell K U, Weil J. Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J GastroenterolHepatol 1991; 3: 923–6
   Web of Science ®Google Scholar
• Weil J, Bell G D, Powell K U. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991; 5: 309–13
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M. Does a previous course of tripotassium dicitrato-bismuthate affect the subsequent chances of successful Helicobacter pylori eradication. Aliment PharmacolTher 1992; 6: 327–33
   PubMedGoogle Scholar
• Bell G D, Powell K U, Burridge S M. Experience with ‘triple’ anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427–35
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol. Ther 1992; 6: 751–8
   PubMed Web of Science ®Google Scholar
• Borody T, Andrews P, Mancuso N, Jankiewicz E, Brandl S. Helicobacter pylori reinfection 4 years post-eradication. Lancet 1992; 339: 1295
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Blaser M J, Perez-Perez G I, Hargrett-Bean N, Tauxe R V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41–6
   PubMed Web of Science ®Google Scholar
• Weil J, Bell G D, Powell K U. Helicobacter pylori and metronidazole resistance. Lancet 1990; 336: 1445
   PubMed Web of Science ®Google Scholar
• Borody T J. Possibilities for Helicobacter pylori suppression/ eradication. Eur J Gastroenterol Hepatol 1992; 4(Suppl 2)S37–40
   Google Scholar
• Logan R PH, Gummett P A, Misiewicz J J, Karim Q N, Walker M M, Baron J H. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 1249–52
   PubMed Web of Science ®Google Scholar
• Lamouliatte H, Megraud F, de Mascarel A. Does omeprazole improve amoxycillin therapy directed towards C. pylori-associated chronic gastritis?. Proceedings of the Second Meeting of the European Campylobacter pylori Study Group, Klin Wochenschr, 1989; 67: 37
   Google Scholar
• Unge P, Eriksson K, Bergman B. Omeprazole and amoxycillin in patients with duodenal ulcer: Helicobacter pylori eradication and remission of ulcers and symptoms during a 6-month follow-up. A double-blind comparative study. Gastroenterology 1992; 102: A183
   Google Scholar
• Labenz J, Gyenes F, Ruhl G H, Borsch G. Amoxycillin-omeprazole treatment for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 38
   Google Scholar
• Labenz J, Gyenes F, Rühl G H, Börsch G. Zweiwochige Amoxycillin/Omeprazole–Therapie zur Helicobacter pylori-Eradikation. Klin Wochenschr 1992; 69: 37
   Google Scholar
• Logan R PH, Gummett P A, Hegarty B T, Walker M M, Baron J H, Misiewicz J J. Clarithromycin and omeprazole for Helicobacter pylori. Lancet 1992; 340: 239
   PubMed Web of Science ®Google Scholar